Immediate Impact

61 standout
Sub-graph 1 of 24

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
2 intermediate papers

Works of Tai-Yi Chen being referenced

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients
2008

Author Peers

Author Last Decade Papers Cites
Tai-Yi Chen 304 381 73 174 27 500
Martin J. Dib 278 315 78 167 23 497
G.C. Sotiropoulos 272 255 54 131 36 438
C Benasco 224 343 41 225 27 523
Wenzel Schoening 294 192 58 98 31 450
F. Tuci 247 347 31 212 24 498
Hirofumi Kanemura 230 204 53 119 24 527
Maarouf Hoteit 167 368 56 218 37 495
Sung-Hwa Kang 402 328 167 94 31 543
Erik M. Schlicht 206 389 113 311 22 516
Chin‐Hsiang Yang 397 375 60 103 27 511

All Works

Loading papers...

Rankless by CCL
2026